Evidence map›Paper›PMID 36083424›Full record

ArticleMetabolic brain disease2022

Nanoselenium improved learning, memory, and brain-derived neurotrophic factor and attenuated nitric oxide, and oxidative stress in the brain of juvenile hypothyroid rats.

Fatemeh Hojjati Fard, Fereshteh Sabzi, Narges Marefati, Farzaneh Vafaee, Farimah Beheshti, Alireza Hashemzadeh, Majid Darroudi, Mahmoud Hosseini

Abstract read
PubMed Publisher
In one paragraph

Article in Metabolic brain disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Fatemeh Hojjati Fard *Psychiatry and Behavioral Sciences Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID 0000-0002-0668-2773
Fereshteh Sabzi *Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID 0000-0003-3654-1346
Narges MarefatiDepartment of Physiology and Medical Physics, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-9954-3296
Farzaneh VafaeeNeuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID 0000-0002-9821-3447
Farimah BeheshtiNeuroscience Research Center, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran.ORCID 0000-0003-1524-2339
Alireza HashemzadehDepartment of Physiology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID 0000-0001-7460-3312
Majid DarroudiNuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID 0000-0002-2624-7242
Mahmoud HosseiniApplied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. hosseinim@mums.ac.ir.ORCID 0000-0001-6425-5123
Mashhad University of Medical Sciences · IRBaqiyatallah University of Medical Sciences · IRTorbat Heydarieh University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNanoselenium (Nan S) is a form of selenium element that acts with high absorption and low toxicity. However, few studies have examined the effects of Nan S on cognitive impairment. On the other hand, hypothyroidism is a common disease that causes cognitive disorders. Therefore, this study aimed to investigate the effect of Nan S on memory impairment in rats due to propylthiouracil (PTU) - induced hypothyroidism. The roles of brain-derived neurotrophic factor (BDNF), nitric oxide (NO), and oxidative stress were also challenged. MATERIALS AND

methodsThe animals were randomly divided into 4 groups: (1) Control group (normal saline), (2) hypothyroid (Hypo) group: where 0.05% PTU was added to drinking water, (3) and (4) Hypo-Nan S 50, Hypo-Nan S 100 in which 50 or 100 µg/ kg of Nan S were injected respectively. After 6 weeks, spatial and avoidance memory was measured by Morris water maze (MWM) and passive avoidance (PA) tests. The animals then underwent deep anesthesia and the serum samples and the hippocampus and cortex were collected to be used for thyroxin and biochemical measurements including malondialdehyde (MDA), NO, thiol, superoxide dismutase (SOD), catalase (CAT), and BDNF.

resultsThe rats showed an increase in the escape latency and traveled path in MWM in the Hypo group compare with the Control group and these parameters were decreased in both Hypo-Nan S 50 and Hypo-Nan S 100 groups compared to the Hypo group. The rats of both Hypo-Nan S 50 and Hypo-Nan S 100 groups spent longer time and traveled longer distances in the target area during the probe trial of MWM than the Hypo group. In addition, the latency to enter the dark box in the PA test was lower in the Hypo group than in the Control group, which was significantly improved after Nan S treatment. Furthermore, the hippocampal and cortical lipid peroxide marker (MDA) levels and NO metabolites of the Hypo group were significantly increased and the antioxidant markers (total thiol, SOD, and CAT) were significantly inhibited compared to the Control group. Compared with the Hypo group, Nan S administration could significantly decrease the oxidant factors and increase the activities antioxidant system and concentration of BDNF.

conclusionIt is concluded that Nan S might be able to enhance endogenous antioxidant proteins due to its antioxidant activity, thereby improving BDNF and spatial and avoidance memory in the hypothyroidism-induced memory impairment model however, more studies are still necessary to elucidate the exact mechanism(s).

Indexed as

Brain-Derived Neurotrophic FactorHypothyroidismAnimalsAntioxidantsBrainHippocampusMaze LearningMemory DisordersNitric OxideOxidative StressPropylthiouracilRatsRats, WistarSulfhydryl CompoundsSuperoxide DismutaseAntioxidantsBrain-Derived Neurotrophic FactorNitric OxidePropylthiouracilSulfhydryl CompoundsSuperoxide DismutaseHypothyroidismLearningMemoryNanoseleniumNeuroprotectiveOxidative stress

Identifiers

PMID36083424
OpenAlexW4295021498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.